VOYA Investment Management
AMLX icon

VOYA Investment Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

VOYA Investment Management’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$321K Buy
17,847
+2,620
+17% +$40.5K ﹤0.01% 2024
2026
Q1 		$212K Sell
15,227
-20
-0.1% -$281 ﹤0.01% 2097
2025
Q4 		$184K Buy
15,247
+2,257
+17% +$30.7K ﹤0.01% 2166
2025
Q3 		$177K Sell
12,990
-6,486
-33% -$61K ﹤0.01% 2213
2025
Q2 		$125K Buy
+19,476
New +$94.7K ﹤0.01% 2437
2024
Q2 		– Sell
-17,357
Closed -$49.3K – 2827
2024
Q1 		$49.3K Sell
17,357
-2,818
-14% -$36.9K ﹤0.01% 2729
2023
Q4 		$297K Sell
20,175
-1,125,613
-98% -$17.3M ﹤0.01% 2353
2023
Q3 		$21M Buy
1,145,788
+208,248
+22% +$4.4M 0.02% 490
2023
Q2 		$20.2M Buy
937,540
+318,510
+51% +$8.6M 0.02% 511
2023
Q1 		$18.2M Buy
619,030
+576,884
+1,369% +$20M 0.02% 552
2022
Q4 		$1.56M Buy
42,146
+28,611
+211% +$1.02M ﹤0.01% 1434
2022
Q3 		$381K Buy
+13,535
New +$338K ﹤0.01% 2199

Other funds holding AMLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

VOYA Investment Management's AMLX Position: Q2 2026 in Review

VOYA Investment Management increased its Amylyx Pharmaceuticals (AMLX) stake by 17% in Q2 2026, buying an estimated $40.5K and bringing the position to 17,847 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #2024.

VOYA Investment Management first reported a position in AMLX in Q3 2022 and has held it in 12 quarters since. The position peaked at $21M in Q3 2023. 206 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

  • VOYA Investment Management held 17,847 shares of Amylyx Pharmaceuticals worth $321K as of Q2 2026.
  • VOYA Investment Management bought 2,620 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $40.5K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2024 holding.
  • VOYA Investment Management first reported a position in Amylyx Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
  • VOYA Investment Management's Amylyx Pharmaceuticals position peaked at $21M in Q3 2023.
  • 206 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.